NSE BSE
tejnaksh healthcare limited stock

Tejnaksh Healthcare Limited Share Price

- - (%)
Sector: -

539428

TEJNAKSH

img img img img
No Data Available

Tejnaksh Healthcare Limited : Share Price Update


As of the latest trading session, Tejnaksh Healthcare Limited share price is currently at 25.48, which is up by 0.21 from its previous closing. Today, the stock has fluctuated between 24.27 and 26.41. Over the past year, Tejnaksh Healthcare Limited has achieved a return of -32.49 %. In the last month alone, the return has been 1.20 %.

Tejnaksh Healthcare Limited Performance

Day Range

Low24.27 High26.41
24.44

52 Week Range

Low 22.55 High 39.00
24.44

Open Price

26.41

Prev. Close

25.26

Volume (Shares)

4752.00

Total traded value

1.16

Upper Circuit

29.24

Lower Circuit

19.50

Note: The current prices & values are delayed, Login to your account for live updates.

Tejnaksh Healthcare Limited Fundamentals


(Standalone)

Market Cap (Cr) 25.87
PE Ratio (TTM) 45.11
Book Value / Share 10.63
Beta 0.72
ROE 6.81%
EPS (TTM) 0.56
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.55

Tejnaksh Healthcare Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 2.10
Operating Expense 1.44
Net Profit 0.55
Net Profit Margin (%) 26.19
Earnings Per Share (EPS) 0.27
EBITDA 1.13
Effective Tax Rate (%) 24.65
Particulars SEP 2023 (Values in Cr)
Revenue 2.06
Operating Expense 1.46
Net Profit 0.50
Net Profit Margin (%) 24.27
Earnings Per Share (EPS) 0.24
EBITDA 1.04
Effective Tax Rate (%) 25.37
Particulars JUN 2023 (Values in Cr)
Revenue 1.92
Operating Expense 1.77
Net Profit 0.16
Net Profit Margin (%) 8.33
Earnings Per Share (EPS) 0.08
EBITDA 0.59
Effective Tax Rate (%) 27.27
Particulars MAR 2023 (Values in Cr)
Revenue 1.65
Operating Expense 1.73
Net Profit -0.07
Net Profit Margin (%) -4.24
Earnings Per Share (EPS) -0.06
EBITDA 0.41
Effective Tax Rate (%) 333.33
Particulars DEC 2022 (Values in Cr)
Revenue 1.65
Operating Expense 1.29
Net Profit 0.30
Net Profit Margin (%) 18.18
Earnings Per Share (EPS) 0.29
EBITDA 0.75
Effective Tax Rate (%) 25.00
Particulars MAR 2023 (Values in Cr)
Revenue 7.34
Operating Expense 5.60
Net Profit 1.38
Net Profit Margin (%) 18.80
Earnings Per Share (EPS) 1.36
EBITDA 3.36
Effective Tax Rate (%) 29.59
Particulars MAR 2022 (Values in Cr)
Revenue 8.12
Operating Expense 4.88
Net Profit 2.52
Net Profit Margin (%) 31.03
Earnings Per Share (EPS) 2.48
EBITDA 4.43
Effective Tax Rate (%) 25.22
Particulars MAR 2021 (Values in Cr)
Revenue 8.56
Operating Expense 6.13
Net Profit 2.00
Net Profit Margin (%) 23.36
Earnings Per Share (EPS) 1.97
EBITDA 3.73
Effective Tax Rate (%) 22.77
Particulars MAR 2020 (Values in Cr)
Revenue 11.14
Operating Expense 9.33
Net Profit 1.92
Net Profit Margin (%) 17.23
Earnings Per Share (EPS) 1.89
EBITDA 4.05
Effective Tax Rate (%) 27.81
Particulars MAR 2019 (Values in Cr)
Revenue 13.96
Operating Expense 11.63
Net Profit 2.69
Net Profit Margin (%) 19.26
Earnings Per Share (EPS) 2.65
EBITDA 5.03
Effective Tax Rate (%) 28.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.43
ROE % 8.56
ROCE % 11.24
Total Debt to Total Equity 0.32
EBITDA Margin 34.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.75
ROE % 15.03
ROCE % 17.08
Total Debt to Total Equity 0.32
EBITDA Margin 38.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 17.05
ROE % 12.71
ROCE % 14.10
Total Debt to Total Equity 0.37
EBITDA Margin 32.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 15.02
ROE % 15.14
ROCE % 17.72
Total Debt to Total Equity 0.48
EBITDA Margin 25.58
Particulars MAR 2019 (Values in Cr)
Book Value / Share 12.96
ROE % 26.95
ROCE % 27.61
Total Debt to Total Equity 0.60
EBITDA Margin 29.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.62
ROE % 6.81
ROCE % 9.41
Total Debt to Total Equity 0.33
EBITDA Margin 45.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.25
ROE % 13.77
ROCE % 15.63
Total Debt to Total Equity 0.33
EBITDA Margin 54.68
Particulars MAR 2021 (Values in Cr)
Book Value / Share 16.76
ROE % 12.48
ROCE % 13.82
Total Debt to Total Equity 0.38
EBITDA Margin 43.69
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.78
ROE % 13.67
ROCE % 16.39
Total Debt to Total Equity 0.48
EBITDA Margin 35.22
Particulars MAR 2019 (Values in Cr)
Book Value / Share 12.89
ROE % 22.90
ROCE % 24.11
Total Debt to Total Equity 0.59
EBITDA Margin 36.10
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.13
Total Assets 31.22
Total Liabilities 31.22
Total Equity 22.41
Share Outstanding 10156800
Price to Book Ratio 3.34
Return on Assets (%) 5.38
Return on Capital (%) 5.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 29.60
Total Liabilities 29.60
Total Equity 20.59
Share Outstanding 10156800
Price to Book Ratio 8.75
Return on Assets (%) 9.19
Return on Capital (%) 10.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 24.57
Total Liabilities 24.57
Total Equity 17.76
Share Outstanding 10156800
Price to Book Ratio 4.34
Return on Assets (%) 8.35
Return on Capital (%) 9.35
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.29
Total Assets 24.90
Total Liabilities 24.90
Total Equity 15.68
Share Outstanding 10156800
Price to Book Ratio 2.44
Return on Assets (%) 8.39
Return on Capital (%) 9.38
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 22.26
Total Liabilities 22.26
Total Equity 13.53
Share Outstanding 10156800
Price to Book Ratio 4.31
Return on Assets (%) 13.58
Return on Capital (%) 15.52
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.47
Total Assets 29.80
Total Liabilities 29.80
Total Equity 20.94
Share Outstanding 10156800
Price to Book Ratio 3.34
Return on Assets (%) 4.62
Return on Capital (%) 5.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 28.67
Total Liabilities 28.67
Total Equity 19.55
Share Outstanding 10156800
Price to Book Ratio 8.75
Return on Assets (%) 8.78
Return on Capital (%) 9.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.56
Total Assets 23.87
Total Liabilities 23.87
Total Equity 17.02
Share Outstanding 10156800
Price to Book Ratio 4.34
Return on Assets (%) 8.39
Return on Capital (%) 9.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.02
Total Assets 24.28
Total Liabilities 24.28
Total Equity 15.01
Share Outstanding 10156800
Price to Book Ratio 2.44
Return on Assets (%) 7.92
Return on Capital (%) 8.88
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.96
Total Assets 21.40
Total Liabilities 21.40
Total Equity 13.08
Share Outstanding 10156800
Price to Book Ratio 4.31
Return on Assets (%) 12.57
Return on Capital (%) 14.14
Particulars MAR 2023 (Values in Cr)
Net Income 2.51
Cash from Operations 1.70
Cash from Investing -1.40
Cash from Financing -1.19
Net change in Cash -0.47
Free Cash Flow 2.52
Particulars MAR 2022 (Values in Cr)
Net Income 3.76
Cash from Operations 8.96
Cash from Investing -10.58
Cash from Financing 1.61
Net change in Cash 0.23
Free Cash Flow 18.04
Particulars MAR 2021 (Values in Cr)
Net Income 2.66
Cash from Operations 0.47
Cash from Investing 1.55
Cash from Financing -2.80
Net change in Cash -0.06
Free Cash Flow 0.91
Particulars MAR 2020 (Values in Cr)
Net Income 2.96
Cash from Operations 1.64
Cash from Investing -1.20
Cash from Financing 0.10
Net change in Cash 0.05
Free Cash Flow 2.72
Particulars MAR 2019 (Values in Cr)
Net Income 4.36
Cash from Operations 3.92
Cash from Investing -1.55
Cash from Financing -2.09
Net change in Cash -0.49
Free Cash Flow 5.10
Particulars MAR 2023 (Values in Cr)
Net Income 1.96
Cash from Operations 1.51
Cash from Investing -0.98
Cash from Financing -1.17
Net change in Cash -0.25
Free Cash Flow 2.20
Particulars MAR 2022 (Values in Cr)
Net Income 3.37
Cash from Operations 8.88
Cash from Investing -10.39
Cash from Financing 1.61
Net change in Cash 0.34
Free Cash Flow 17.74
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations 0.34
Cash from Investing 1.55
Cash from Financing -2.86
Net change in Cash -0.46
Free Cash Flow 0.78
Particulars MAR 2020 (Values in Cr)
Net Income 2.66
Cash from Operations 1.29
Cash from Investing -1.15
Cash from Financing 0.21
Net change in Cash 0.06
Free Cash Flow 2.31
Particulars MAR 2019 (Values in Cr)
Net Income 3.74
Cash from Operations 3.92
Cash from Investing -1.49
Cash from Financing -2.08
Net change in Cash -0.42
Free Cash Flow 5.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
Tejnaksh Healthcare Limited 25.26 40.74 2.27 51.31 22.55 / 38.90
APOLLO HOSPITALS ENTER. L 5931.30 108.22 13.11 85282.99 4410.05 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 72.93 0.00 2.30 136.68 44.00 / 107.94
SHREE PACETRONIX LTD. 215.15 19.94 6.91 77.44 121.60 / 391.90
TRANSGENE BIOTEK LTD. 6.47 0.00 4.41 49.02 3.57 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
Tejnaksh Healthcare Limited 25.26 45.11 2.37 51.31 22.55 / 38.90
APOLLO HOSPITALS ENTER. L 5931.30 85.40 11.69 85282.99 4410.05 / 6871.30
Tejnaksh Healthcare Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 34.43 95.64 144.24 25.72 19.50 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4022.10 27.83 5.63 4400.18 1968.15 / 4271.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 24.20
  • 26 Days 24.50
  • 10 Days 24.10
  • 50 Days 25.10
  • 12 Days 24.00
  • 100 Days 26.70
  • 20 Days 24.20
  • 200 Days 33.70
25.22
PIVOT
First Resistance 26.04
Second Resistance 26.82
Third Resistance 27.64
First Support 24.44
Second Support 23.62
Third Support 22.84
RSI 55.27
MACD -0.50
Commodity Channel Index (CCI) 124.05
ADX 12.06
Williams % R -21.45

Over 1 Month

down

1.20

Over 3 Months

down

-15.23

Over 6 Months

down

-24.66

Over 1 Year

down

-32.49

Over 3 Years

down

-7.62

Over 5 Years

down

-0.40

Tejnaksh Healthcare Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Tejnaksh Healthcare Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
25.88
Promoter Holdings
73.83
FII
0.27
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ashish Vishwas Rawandale Shareholding of Promoter and Promoter Group 7749202.0 38.15
Preeti Ashish Rawandale Shareholding of Promoter and Promoter Group 7217932.0 35.53
Prashant Janardan More Public Shareholding 339066.0 1.67
Sheetal Utkarsh Rawandale Public Shareholding 294400.0 1.45
Guntupalli Sivaramakrishna Public Shareholding 273762.0 1.35
Pramila Vishwasrao Patil Shareholding of Promoter and Promoter Group 31018.0 0.15
Utkarsh Vishwas Rawandale Shareholding of Promoter and Promoter Group 18.0 0.0

Tejnaksh Healthcare Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2018-04-28 2018-04-26 36:10 2017-03-09 2017-03-08 1:1
Ex-Date Old FV NEW FV Record Date
2023-07-19 10.0 5.0 2023-07-19

Learn More About Stocks

About Tejnaksh Healthcare Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Tejnaksh Healthcare Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Tejnaksh Healthcare Ltd?

Answer Field

The share price of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and for BSE is ₹ 25.48.

What is the Market Cap of Tejnaksh Healthcare Ltd?

Answer Field

The market cap of Tejnaksh Healthcare Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 25.87 Cr. as of now.

What is the 52 Week High and Low of Tejnaksh Healthcare Ltd?

Answer Field

The 52 Week High and Low of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 38.90 and ₹ 22.55.

How to Buy Tejnaksh Healthcare Ltd share?

Answer Field

You can trade in Tejnaksh Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Tejnaksh Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -32.49%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader